GlassScriptPhysician profile
Michael A Glass
NPI 1164425047
$3,654.55
in general payments reported to CMS, 2019-2025
38 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,314 · 2020: $194 · 2021: $469 · 2022: $744 · 2023: $579 · 2024: $144 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.80 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $572.82 | 2019-2023 | Xtandi |
| Boston Scientific Corporation | $568.43 | 2019-2024 | Rezum Generator, Lithovue |
| Abbvie INC. | $235.85 | 2019-2024 | |
| Intuitive Surgical, INC. | $235.32 | 2019 | |
| Janssen Biotech, INC. | $220.59 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $192.54 | 2019-2024 | |
| Coloplast Corp | $185.68 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $144.66 | 2023-2024 | Orgovyx, Gemtesa |
| Axonics, INC. | $142.61 | 2022-2024 | Bulkamid, Axonics |
| Myovant Sciences INC. | $113.23 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $98.95 | 2023 | Pylarify |
| Medtronic, INC. | $90.16 | 2021 | |
| Amgen INC. | $77.46 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $61.52 | 2022-2023 | Seglentis |
| Dentsply Ih INC. | $57.27 | 2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $56.71 | 2022 | |
| Myriad Genetic Laboratories, INC. | $55.83 | 2023 | Myrisk |
| Blue Earth Diagnostics | $53.82 | 2019 | |
| Ferring Pharmaceuticals INC. | $47.51 | 2019 | |
| Dendreon Pharmaceuticals LLC | $47.26 | 2019-2022 | |
| Bard Access Systems, INC. | $46.72 | 2019 | |
| 180 Medical, INC. | $35.92 | 2019-2020 | |
| Urogen Pharma, INC. | $32.58 | 2022 | |
| Merck Sharp & Dohme LLC | $31.00 | 2023 | Lynparza, Keytruda, Welireg |
| Pfizer INC. | $29.22 | 2023 | |
| Avadel Specialty Pharmaceuticals, LLC | $24.78 | 2019 | |
| Ambu INC. | $19.48 | 2021 | |
| Procept Biorobotics Corporation | $18.85 | 2022 | |
| Angiodynamics, INC. | $18.78 | 2021 | |
| Baxter Healthcare | $18.69 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $16.96 | 2022 | |
| Urovant Sciences INC | $16.79 | 2022 | |
| Rochester Medical Corporation | $16.75 | 2021 | |
| Therapeuticsmd, INC. | $14.64 | 2019 | |
| Endo Pharmaceuticals INC. | $14.51 | 2019 | |
| Agiliti Surgical, INC. | $14.40 | 2019 | |
| Dentsply Ih Ab | $13.42 | 2023 | Lofric |
| Aytu Biopharma, INC. | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Glass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.